Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Specifar Pharmaceuticals SA

Division of Allergan PLC
www.specifar.gr

Latest From Specifar Pharmaceuticals SA

Actavis’ Transformative Dealmaking

A steady stream of M&A and licensing activity, starting with the buyout of Andrx in 2006, spurred Actavis’ a.k.a. Watson’s transformation into a global specialty pharma. This led the way to the 2012 merger with Actavis and now the proposed buyout of Forest, creating a new, global specialty and generics player.

BioPharmaceutical Strategy

Watson’s Transformative Deal-Making

A steady stream of M&A and licensing activity, starting with the buyout of Andrx in 2006, spurred Watson’s transformation into a global specialty pharma. This led the way to the 2012 merger with Actavis and now the proposed buyout of Forest, creating a new, global specialty and generics player.

BioPharmaceutical Business Strategies

Watson Becomes Actavis: Name Change To Reflect Greater International Focus

Watson’s merger with Actavis will create the world’s third-largest generic drug company, to be known as Actavis, with significant ex-U.S. market share, especially in the U.K., Nordic countries and Russia.

BioPharmaceutical North America

German Specialty Pharma Firm Riemser Arzneimittel Bought By AXA Private Equity

AXA Private Equity's acquisition of Riemser Arzneimittel is the third change of ownership in the European specialty pharmaceuticals and manufacturing sectors this month, with more likely to follow as buyout specialists seeks the right combination of companies for consolidation.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Greece
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Petros Vourtsis, Head, Sales & Mktg.
    Chris Papathanasiou , Head, In-Licensing
  • Contact Info
  • Specifar Pharmaceuticals SA
    Phone: 210 54 01 500
    1, 28 Octovriou Str.
    Ag.Varvara
    Athens, 123 51
    Greece
UsernamePublicRestriction

Register